Patent details

EP3896088 Title: TREATMENT OF PERIPHERAL T CELL LYMPHOMA

Basic Information

Publication number:
EP3896088
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP211669262
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF PERIPHERAL T CELL LYMPHOMA
French Title of Invention:
TRAITEMENT DE LYMPHOME T PÉRIPHÉRIQUE
German Title of Invention:
BEHANDLUNG VON PERIPHEREN T-ZELL-LYMPHOMEN
SPC Number:

Dates

Filing date:
20/02/2014
Grant date:
23/07/2025
EP Publication Date:
20/10/2021
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/07/2025
EP B1 Publication Date:
23/07/2025
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/02/2034
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/07/2025
 
 

Name:
Innate Pharma
Address:
117, Avenue de Luminy, 13009 Marseille, France (FR)

Inventor

1

Name:
BUFFET, Renaud
Address:
France (FR)

2

Name:
SICARD, Hélène
Address:
France (FR)

3

Name:
BONNAFOUS, Cécile
Address:
France (FR)

Priority

1

Priority Number:
201361766798 P
Priority Date:
20/02/2013
Priority Country:
United States (US)

2

Priority Number:
201361831809 P
Priority Date:
06/06/2013
Priority Country:
United States (US)

Classification

IPC classification:
C07K 16/28; C07K 16/30; A61P 35/00; A61K 39/395;

Publication

European Patent Bulletin

Issue number:
202530
Publication date:
23/07/2025
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
31/08/2026
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Penalty Fee Amount:
20 Euro
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages